Jennifer Jarrett - Jun 9, 2025 Form 4 Insider Report for Sagimet Biosciences Inc. (SGMT)

Role
Director
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact
Stock symbol
SGMT
Transactions as of
Jun 9, 2025
Transactions value $
$0
Form type
4
Date filed
6/10/2025, 05:38 PM
Previous filing
May 22, 2025
Next filing
Oct 8, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Jarrett Jennifer Director SAGIMET BIOSCIENCES INC., 155 BOVET ROAD, SUITE 303, SAN MATEO /s/ Elizabeth Rozek, Attorney-in-Fact 2025-06-10 0001671311

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SGMT Stock Option (Right to Buy) Award $0 +27.3K $0.00 27.3K Jun 9, 2025 Series A Common Stock 27.3K $5.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 9, 2025, subject to the Reporting Person's continued service on each such vesting date.